Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017 | MMWR

Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017 | MMWR

Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017

Weekly / September 11, 2020 / 69(36);1265–1268

Marci K. Sontag, PhD1,2; Careema Yusuf, MPH3; Scott D. Grosse, PhD4; Sari Edelman, MPH3; Joshua I. Miller, MPH1,2; Sarah McKasson, MPH1,2; Yvonne Kellar-Guenther, PhD1,5; Marcus Gaffney4; Cynthia F. Hinton, PhD6; Carla Cuthbert, PhD6; Sikha Singh, MHS3; Jelili Ojodu, MPH3; Stuart K. Shapira, MD, PhD4 (View author affiliations)

Summary

What is already known about this topic?

Previous modeled estimates of the number of infants identified by newborn screening (NBS), in conjunction with CDC’s Hearing Screening and Follow-up Survey data, predicted approximately 10,500 cases of NBS disorders in the United States in 2006 (25.5 per 10,000 births).

What is added by this report?

This first national report based on reported cases from all 50 states estimates that approximately 12,900 births might be identified each year with an NBS disorder included in the study (34.0 per 10,000 births).

What are the implications for public health practice?

NBS continues to be one of the most successful public health interventions, offering early detection and intervention to all infants, regardless of geographic, ethnic, or socioeconomic differences.